ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.

Andrea Valentine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.